Table 1.

Demographics and clinical findings in patients with ARF after treatment with OSPS bowel purgativea

PatientAgeRaceGenderHTNDiabetesMedicationsLaboratory Parameters at Presentation
ACE-IARBDiureticNSAID24-H Urine ProteinSerum Calciumb (mg/dl)Serum Phosphorusb (mg/dl)
169WMYNY412 mg9.15.6
282BMYN1+8.84.6
355HFYYYY92 mg9.54.0, 4.6c
464BFYYYY1.2 g10.3NA
576WFYNYTrace8.66.6 (day 3)
653WMYNY120 mg92.6
781WFNN600 mg8.54.3
882WFYNYY123 mg9.24.1
957WFYNYTrace9.110.2 (day 3)
1076WFYNY472 mg8.74.5
1174WFYNY200 mg9NA
1257WFNN140 mg8.86.7 (day 2)
1343BFYYYYY130 mgNANA
1439WFNNNegative8.54.3
1569WFYNY500 mg9.74.1
1666WFYYYNegative9.43.2
1751WFYNY197 mg9.13.5
1879WFNNTrace9.1NA
1944WMYNYY95 mg9.2NA
2062WFNN250 mg9.44.6
2164WFYNYNegative10.24.4
  • a ARF, acute renal failure; OSPS, oral sodium phosphate solution; W, white; B, black; H, Hispanic; M, male; F, female; HTN, hypertension; Y, yes; N, no; ACE-I, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; NSAID, nonsteroidal anti-inflammatory drug; NA, not available.

  • b Normal range for serum calcium 8.4 to 10.3 mg/dl; for serum phosphorus 2.5 to 4.5 mg/dl.

  • c On two separate determinations.